A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms

INTRODUCTION: The RNA N6-methyladenosine (m6A) regulators play a crucial role in tumorigenesis and could be indicators of prognosis and therapeutic targets in various cancers. However, the expression status and prognostic value of m6A regulators have not been studied in pancreatic neuroendocrine neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xianlong, Mo, Shengwei, Zong, Liju, Yu, Shuangni, Lu, Zhaohui, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808770/
https://www.ncbi.nlm.nih.gov/pubmed/35609514
http://dx.doi.org/10.1159/000525228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808770/
https://www.ncbi.nlm.nih.gov/pubmed/35609514
http://dx.doi.org/10.1159/000525228

Ejemplares similares